Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07812012) titled 'The Potential of Mesenchymal Stromal Stem Cells to Correct Immune and Metabolic Dysfunctions in Circulating Immune Cells During Sepsis: An Ex Vivo Pilot Study' on Sept. 4.
Study Type: Observational
Primary Sponsor: Centre Hospitalier Universitaire Dijon
Condition:
Sepsis
Intervention:
Biological: Blood sample
Recruitment Status: Not recruiting
Date of First Enrollment: September 2026
Target Sample Size: 51
Countries of Recruitment:
France
To know more, visit https://clinicaltrials.gov/study/NCT07812012
Published by HT Digital Content Services with permission from Health Daily Digest....